Shorter radiotherapy trumpeted for high-risk prostate cancer Women’s breast cancer risk overstated?Researcher says often-quoted figure is double the real value Prophylactic treatments reduce rash associated with colon CA drug Assay predicts chemotherapy response in NSCLC patients Those whose tumours lack MSH2 protein most likely to benefit from cisplatin YOUR TURN: A plea for colonoscopy screening Recently I have been regularly holding the hand of a wealthy friend whose colon cancer was first diagnosed after metastasis. Migraine sufferers have lower breast cancer risk CANCER: Mortality rate spike seen in smokers on HRT combo Eight-year study finds 61% greater likelihood of death from NSCLC CANCER: Erlotinib-bevacizumab combo beats bevacizumab alone CANCER: Second-line chemotherapy patients benefit from vandetanib Drop of 21% in risk of disease progression seen after 13-month followup CANCER: Pemetrexed boosts non-small cell survival rates Patients with nonsquamous cell carcinoma live up to 5.2 months longer, research shows First Previous 74 75 76 77 78 Next Last
